Edgewise Therapeutics EWTX
NASDAQ EWTX
$40.06 +0.31 (+0.77%)
As of: Oct 21, 2026 · 10:00 AM EDT

Edgewise Therapeutics (EWTX) Notes Payables (2022)

Updated

Edgewise Therapeutics' Notes Payables was $7,000 in Q3 2022.

Analysis

Edgewise Therapeutics (EWTX) Notes Payables (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.25 Bn 1,104.84 Bn 19.71 Bn
2 Johnson & Johnson 615.56 Bn 534.09 Bn 17.26 Bn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn
5 Novartis Ag 298.15 Bn 262.14 Bn 11.24 Bn
6 Astrazeneca 262.32 Bn 236.01 Bn 12.86 Bn
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn
8 Gilead Sciences 191.30 Bn 165.50 Bn 6.22 Bn
9 Pfizer 170.97 Bn 117.62 Bn 10.94 Bn
10 Edgewise Therapeutics 4.31 Bn 2.72 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 7,000.00
API Access

Edgewise Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=EWTX&period=max&api_key=YOUR_API_KEY